News All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen Staff January 26, 2024 Please read the full announcement in PDF Attachment 2024_01_All_Regulatory_Approvals_Obtained Iframe sync Post navigation Previous: Additional ODM-208/MK-5684 Phase II data presented at ASCO-GU 2024Next: All necessary regulatory approvals have been obtained for the combination of Novozymes and Chr. Hansen More Stories Clinical Trial News Pharmaceutical NervGen Pharma Announces Proposed Amendment to Warrants Staff December 12, 2025 Financial News MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement Staff December 12, 2025 News Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend Staff December 12, 2025
